β2‐Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade

Regional infusions of β2‐adrenoceptor (ADRB2) agonist have generally shown that individuals homozygous for Gly16 produces greater vasodilatation than those homozygous for Arg16. Systemic infusions have shown an opposite effect on systemic vascular resistance (SVR), possibly confounded by baroreflexes or interactions between single nucleotide polymorphism (SNP) positions 16 and 27. We tested the hypothesis that ADRB2 gene variation would influence the SVR response to ADRB2 agonist terbutaline (Terb) during ganglionic blockade. Forty healthy young adults were recruited according to the double homozygous haplotypes: Arg16 + Gln27 (n= 13), the rare Gly16 + Gln27 (n= 6), and Gly16 + Glu27 (n= 21). Arterial pressure was measured by brachial arterial catheter, and cardiac output by acetylene breathing. Lymphocytes were sampled for ex vivo analysis of ADRB2 density and binding conformation. Following baroreflex ablation with trimethaphan (3–7 mg min−1), continuous phenylephrine was titrated to restore blood pressure to baseline. Terb was infused i.v. at 33 and 67 ng kg−1 min−1 for 15 min/dose. There was partial evidence to suggest a main effect of haplotype on the change in SVR (P= 0.06). For SNP position 16, the highest dose of Terb produced lower SVR in Gly16 (mean ±s.e.m.: 7.5 ± 0.4) vs. Arg16 (8.9 ± 0.7 units; P= 0.03). Lymphocyte ADRB2 binding conformation was similar but receptor density was greater in Gly16 vs. Arg16 (P= 0.05). We conclude that during ganglionic blockade, the SVR response to systemic ADRB2 agonist is suggestive of augmented ADRB2 function in Gly16 + Glu27 homozygotes, with greater influence from Gly16, providing further evidence that ADRB2 gene variation influences vasodilatation.

[1]  W. Kraus,et al.  Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. , 2008, Journal of the American College of Cardiology.

[2]  I. Zineh,et al.  Relation of β2-Adrenoceptor Haplotype to Risk of Death and Heart Transplantation in Patients With Heart Failure , 2007 .

[3]  D. Sorriento,et al.  β2‐Adrenergic receptor polymorphisms and treatment‐induced regression of left ventricular hypertrophy in hypertension , 2006, Clinical pharmacology and therapeutics.

[4]  Bruce D. Johnson,et al.  Dietary sodium restriction and β2‐adrenergic receptor polymorphism modulate cardiovascular function in humans , 2006, The Journal of physiology.

[5]  Bruce D. Johnson,et al.  Genotype related differences in beta2 adrenergic receptor density and cardiac function. , 2006, Medicine and science in sports and exercise.

[6]  T. Lumley,et al.  &bgr;2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death , 2006 .

[7]  Bruce D. Johnson,et al.  Arg16Gly polymorphism of the β2‐adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans , 2006 .

[8]  S. Turner,et al.  Arg16/Gly beta2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise. , 2005, Journal of applied physiology.

[9]  J. Spertus,et al.  β2-Adrenergic Receptor Genotype and Survival AmongPatients Receiving β-Blocker Therapy After an Acute Coronary Syndrome , 2005 .

[10]  Jinny Park,et al.  Human β2‐adrenergic receptor gene haplotypes and venodilation in vivo , 2005, Clinical pharmacology and therapeutics.

[11]  M. Rondon,et al.  Gly16 + Glu27 beta2-adrenoceptor polymorphisms cause increased forearm blood flow responses to mental stress and handgrip in humans. , 2005, Journal of applied physiology.

[12]  M. Joyner,et al.  49 THE ARG16/GLY β2-ADRENERGIC RECEPTOR POLYMORPHISM ALTERS THE CARDIAC OUTPUT RESPONSE TO ISOMETRIC EXERCISE , 2005, Journal of Investigative Medicine.

[13]  A. M. McGuire,et al.  The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. , 2004, Physiological genomics.

[14]  M. Leppert,et al.  The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function☆ , 2003 .

[15]  B. Lipworth,et al.  Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27. , 2003, British journal of clinical pharmacology.

[16]  G. Jennings,et al.  Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. , 2003, Pharmacogenetics.

[17]  T. Lumley,et al.  &bgr;2-Adrenergic Receptor Polymorphisms and Risk of Incident Cardiovascular Events in the Elderly , 2003, Circulation.

[18]  E. Boerwinkle,et al.  β2‐Adrenergic receptor polymorphism and nitric oxide‐dependent forearm blood flow responses to isoproterenol in humans , 2003 .

[19]  Hong-Guang Xie,et al.  Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses , 2003, Journal of hypertension.

[20]  Arya M. Sharma,et al.  Baroreflex Buffering and Susceptibility to Vasoactive Drugs , 2002, Circulation.

[21]  R. Kim,et al.  The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. , 2001, The New England journal of medicine.

[22]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Wheatley,et al.  &bgr;2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans , 2000, Hypertension.

[24]  E. Boerwinkle,et al.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. , 2000, Circulation.

[25]  K. Beck,et al.  Cardiac output during exercise by the open circuit acetylene washin method: comparison with direct Fick. , 2000, Journal of applied physiology.

[26]  F Skrabal,et al.  beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. , 1999, Hypertension.

[27]  J. Jordan,et al.  Uncoupling of the baroreflex by N(N)-cholinergic blockade in dissecting the components of cardiovascular regulation. , 1998, Hypertension.

[28]  S. U. Rahman,et al.  Effect of long-term β2-agonist dosing on human cardiac β-adrenoceptor expression in vivo: Comparison with changes in lung and mononuclear leukocyte β-receptors , 1997 .

[29]  S. Green,et al.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.

[30]  W. J. Merrell,et al.  Low sodium intake corrects abnormality in β‐receptor–mediated arterial vasodilation in patients with hypertension: Correlation with β‐receptor function in vitro , 1990 .

[31]  T. Lumley,et al.  (cid:1) 2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death Epidemiology , 2006 .

[32]  B. Gersh.  β2-Adrenergic Receptor Genotype and Survival Among Patients Receiving β-Blocker Therapy After an Acute Coronary Syndrome , 2006 .

[33]  S. Liggett,et al.  beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. , 2000, American heart journal.

[34]  B. Timmermann,et al.  Agonist-Induced Vasodilation in Young Adult Caucasians ß-2 Adrenergic Receptor Variants Affect Resting Blood Pressure , 1999 .

[35]  A. Salmasi.  Cardiac output during exercise , 1993 .